My name is Kelly Grant and I’m a health reporter with The Globe and Mail, a national newspaper based in Toronto, Canada. I’m researching a story about Remicade, the top-selling drug by revenue in Canada. I’m looking to speak to Canadian Crohn’s and Colitis patients about your experience taking Remicade, particularly about your experience with the company’s BioAdvance patient-assistance program, and with the infusion clinics where you receive your medication. I’m also interested in speaking to you if you are an Ontario patient who has your Remicade costs mostly covered by the Trillium drug program. (But I’m interested in speaking to other Canadian patients, too.) I want to make sure to include the patient experience in any stories I’ll eventually write on this subject.
If you’re interested in speaking with me, I can be reached by e-mail kgrant@globeandmail.com or by phone at 416-585-5334 or 647-688-4214. You can find past examples of my work on my author page at The Globe, where I’m the staff health news reporter. https://www.theglobeandmail.com/authors/kelly-grant/ Thanks for your consideration.
If you’re interested in speaking with me, I can be reached by e-mail kgrant@globeandmail.com or by phone at 416-585-5334 or 647-688-4214. You can find past examples of my work on my author page at The Globe, where I’m the staff health news reporter. https://www.theglobeandmail.com/authors/kelly-grant/ Thanks for your consideration.